Case number 1:22-cv-01096
ZS Pharma, Inc. et al v. Alkem Laboratories Ltd. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 30, 2023 | 50 | CLAIM Construction Chart by AstraZeneca Pharmaceuticals, LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP. (Attachments: # 1 Exhibit 1-10, # 2 Exhibit 11-20, # 3 Exhibit 21, # 4 Exhibit 22, # 5 Exhibit 23-28, # 6 Exhibit 29-40, # 7 Exhibit 41-47, # 8 Exhibit 48-56)(Joyce, Alexandra) (Entered: 06/30/2023) (Exhibit 48-56) (30) |
| Jun 30, 2023 | 50 | CLAIM Construction Chart by AstraZeneca Pharmaceuticals, LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP. (Attachments: # 1 Exhibit 1-10, # 2 Exhibit 11-20, # 3 Exhibit 21, # 4 Exhibit 22, # 5 Exhibit 23-28, # 6 Exhibit 29-40, # 7 Exhibit 41-47, # 8 Exhibit 48-56)(Joyce, Alexandra) (Entered: 06/30/2023) (Exhibit 41-47) (30) |
| Jun 30, 2023 | 50 | CLAIM Construction Chart by AstraZeneca Pharmaceuticals, LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP. (Attachments: # 1 Exhibit 1-10, # 2 Exhibit 11-20, # 3 Exhibit 21, # 4 Exhibit 22, # 5 Exhibit 23-28, # 6 Exhibit 29-40, # 7 Exhibit 41-47, # 8 Exhibit 48-56)(Joyce, Alexandra) (Entered: 06/30/2023) (Exhibit 29-40) (30) |
| Jun 30, 2023 | 50 | CLAIM Construction Chart by AstraZeneca Pharmaceuticals, LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP. (Attachments: # 1 Exhibit 1-10, # 2 Exhibit 11-20, # 3 Exhibit 21, # 4 Exhibit 22, # 5 Exhibit 23-28, # 6 Exhibit 29-40, # 7 Exhibit 41-47, # 8 Exhibit 48-56)(Joyce, Alexandra) (Entered: 06/30/2023) (Exhibit 23-28) (30) |
| Jun 30, 2023 | 50 | CLAIM Construction Chart by AstraZeneca Pharmaceuticals, LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP. (Attachments: # 1 Exhibit 1-10, # 2 Exhibit 11-20, # 3 Exhibit 21, # 4 Exhibit 22, # 5 Exhibit 23-28, # 6 Exhibit 29-40, # 7 Exhibit 41-47, # 8 Exhibit 48-56)(Joyce, Alexandra) (Entered: 06/30/2023) (Exhibit 22) (30) |
| Jun 30, 2023 | 50 | CLAIM Construction Chart by AstraZeneca Pharmaceuticals, LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP. (Attachments: # 1 Exhibit 1-10, # 2 Exhibit 11-20, # 3 Exhibit 21, # 4 Exhibit 22, # 5 Exhibit 23-28, # 6 Exhibit 29-40, # 7 Exhibit 41-47, # 8 Exhibit 48-56)(Joyce, Alexandra) (Entered: 06/30/2023) (Exhibit 21) (30) |
| Jun 30, 2023 | 50 | CLAIM Construction Chart by AstraZeneca Pharmaceuticals, LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP. (Attachments: # 1 Exhibit 1-10, # 2 Exhibit 11-20, # 3 Exhibit 21, # 4 Exhibit 22, # 5 Exhibit 23-28, # 6 Exhibit 29-40, # 7 Exhibit 41-47, # 8 Exhibit 48-56)(Joyce, Alexandra) (Entered: 06/30/2023) (Exhibit 11-20) (30) |
| Jun 30, 2023 | 50 | CLAIM Construction Chart by AstraZeneca Pharmaceuticals, LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP. (Attachments: # 1 Exhibit 1-10, # 2 Exhibit 11-20, # 3 Exhibit 21, # 4 Exhibit 22, # 5 Exhibit 23-28, # 6 Exhibit 29-40, # 7 Exhibit 41-47, # 8 Exhibit 48-56)(Joyce, Alexandra) (Entered: 06/30/2023) (Exhibit 1-10) (30) |
| Jun 30, 2023 | 50 | CLAIM Construction Chart by AstraZeneca Pharmaceuticals, LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP. (Attachments: # 1 Exhibit 1-10, # 2 Exhibit 11-20, # 3 Exhibit 21, # 4 Exhibit 22, # 5 Exhibit 23-28, # 6 Exhibit 29-40, # 7 Exhibit 41-47, # 8 Exhibit 48-56)(Joyce, Alexandra) (Entered: 06/30/2023) (Main Document) (19) |
| Jun 30, 2023 | 49 | NOTICE OF SERVICE of (1) Plaintiff's Objections and Responses to Defendants' First Set of Common Interrogatories, and (2) Plaintiffs' Objections and Responses to Defendants' First Set of Common Requests for Production filed by AstraZeneca Pharmaceuticals, LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP.(Joyce, Alexandra) (Entered: 06/30/2023) (6) |
| Jun 26, 2023 | 48 | STIPULATION TO EXTEND TIME the Deadline to Submit a Joint Technology Tutorial to November 3, 2023 - filed by AstraZeneca Pharmaceuticals, LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP. (Joyce, Alexandra) (Entered: 06/26/2023) (4) |
| Jun 13, 2023 | 47 | NOTICE of WITHDRAWAL OF COUNSEL by Alkem Laboratories Ltd. (Capuzzi, Kevin) (Entered: 06/13/2023) (2) |
| Jun 5, 2023 | 46 | NOTICE OF SERVICE of (1) Plaintiffs' First Set of Common Interrogatories (Nos. 1-5) to Defendants, (2) Plaintiffs' First Individual Interrogatory (No. 1) to Defendants Lupin Ltd. and Lupin Pharmaceuticals, Inc., and (3) Plaintiffs' First Individual Interrogatory (No. 1) to Defendants Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc. filed by AstraZeneca Pharmaceuticals, LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP.(Joyce, Alexandra) (Entered: 06/05/2023) (6) |
| Jun 2, 2023 | 45 | NOTICE OF SERVICE of Plaintiffs' Identification of Claim Terms for Construction filed by AstraZeneca Pharmaceuticals, LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP.(Joyce, Alexandra) (Entered: 06/02/2023) (6) |
| Jun 2, 2023 | 44 | NOTICE OF SERVICE of Defendants' Disclosure of Claim Terms and Proposed Constructions filed by Sandoz Inc., Lupin Limited, Lupin Pharmaceuticals, Inc..(Bilson, David) (Entered: 06/02/2023) (3) |
| May 30, 2023 | 43 | NOTICE OF SERVICE of Defendants' First Set of Common Requests for Production of Documents and Things (Nos. 1-90) and Defendants' First Set of Common Interrogatories (Nos. 1-10) filed by Sandoz Inc., Lupin Limited, Lupin Pharmaceuticals, Inc..(Bilson, David) (Entered: 05/30/2023) (3) |
| Apr 21, 2023 | 42 | Letter to The Honorable Gregory B. Williams from John C. Phillips, Jr. regarding Request to Schedule a Discovery Teleconference. (Phillips, John) (Entered: 04/21/2023) (2) |
| Mar 31, 2023 | 41 | NOTICE OF SERVICE of Plaintiffs' Initial Infringement Contentions with Claim Charts filed by AstraZeneca Pharmaceuticals, LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP.(Joyce, Alexandra) (Entered: 03/31/2023) (6) |
| Mar 3, 2023 | 40 | NOTICE OF SERVICE of Defendants Responses and Objections to Plaintiffs Second Set of Requests to Alkem for the Production of Documents and Things (Nos.11-47) filed by Alkem Laboratories Ltd..(Capuzzi, Kevin) (Entered: 03/03/2023) (2) |
| Feb 24, 2023 | 39 | NOTICE of SERVICE by Alkem Laboratories Ltd. of Paragraph 4(b) Document Production (Capuzzi, Kevin) (Entered: 02/24/2023) (2) |
| Feb 2, 2023 | 38 | PROPOSED ORDER Stipulated Protective Order by AstraZeneca Pharmaceuticals, LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP. (Silver, Daniel) (Entered: 02/02/2023) (30) |
| Feb 1, 2023 | 37 | NOTICE OF SERVICE of Plaintiffs' Second Set of Requests (Nos. 11-47) to Defendants for the Production of Documents and Things filed by AstraZeneca Pharmaceuticals, LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP.(Joyce, Alexandra) (Entered: 02/01/2023) (6) |
| Jan 26, 2023 | 36 | STIPULATION TO EXTEND TIME to submit a Proposed Protective Order to February 2, 2023 - filed by ZS Pharma, Inc., AstraZeneca Pharmaceuticals, LP. (Joyce, Alexandra) (Entered: 01/26/2023) (3) |
| Jan 20, 2023 | 35 | NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Identifying Defendants Accused Products and Plaintiffs' Asserted Patents filed by AstraZeneca Pharmaceuticals, LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP.(Joyce, Alexandra) (Entered: 01/20/2023) (7) |
| Jan 19, 2023 | 34 | NOTICE OF SERVICE of Defendant Alkem Laboratories Ltd.s Initial Disclosures Pursuant to Delawares Default Standard for Discovery of Electronically Stored Information filed by Alkem Laboratories Ltd..(Capuzzi, Kevin) (Entered: 01/19/2023) (2) |
| Jan 19, 2023 | 32 | NOTICE OF SERVICE of Plaintiffs ZS Pharma, Inc. and AstraZeneca Pharmaceuticals LP's Paragraph 3 Disclosures filed by AstraZeneca Pharmaceuticals, LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP.(Silver, Daniel) (Entered: 01/19/2023) (6) |
| Jan 19, 2023 | 33 | STIPULATION Stipulation and [Proposed] Order to Extend Time to Submit Proposed Protective Order by Sandoz Inc., Lupin Limited, Lupin Pharmaceuticals, Inc.. (Bilson, David) (Entered: 01/19/2023) (3) |
| Jan 13, 2023 | 31 | NOTICE OF SERVICE of Defendants Responses and Objections to Plaintiffs Amended First Set of Requests to Alkem for the Production of Documents and Things (Nos.1-10) filed by Alkem Laboratories Ltd..(Capuzzi, Kevin) (Entered: 01/13/2023) (2) |
| Jan 12, 2023 | 30 | NOTICE OF SERVICE of Defendant Alkem Laboratories Ltd.s Initial Disclosures filed by Alkem Laboratories Ltd..(Capuzzi, Kevin) (Entered: 01/12/2023) (2) |
| Jan 12, 2023 | 29 | NOTICE OF SERVICE of Plaintiffs ZS Pharma, Inc. and AstraZeneca Pharmaceuticals LP's Rule 26(a)(1) Initial Disclosures filed by AstraZeneca Pharmaceuticals, LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP.(Joyce, Alexandra) (Entered: 01/12/2023) (6) |
| Jan 9, 2023 | 28 | Official Transcript of Teleconference held on 12/12/2022 before Judge Gregory B. Williams. Court Reporter/Transcriber Dale C. Hawkins,Email: Dale_Hawkins@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 1/30/2023. Redacted Transcript Deadline set for 2/9/2023. Release of Transcript Restriction set for 4/10/2023. (dh) (Entered: 01/09/2023) (6) |
| Dec 29, 2022 | 27 | SCHEDULING ORDER: Fact Discovery completed by 6/14/2024. Status Report due by 2/16/2024. Joint Claim Construction Brief due by 11/10/2023. A Markman Hearing is set for 12/7/2023 at 02:00 PM in Courtroom 6B before Judge Gregory B. Williams. A Final Pretrial Conference is set for 2/27/2025 at 03:00 PM in Courtroom 6B before Judge Gregory B. Williams. A 5-day Bench Trial is set for 3/10/2025 at 09:30 AM in Courtroom 6B before Judge Gregory B. Williams. Signed by Judge Gregory B. Williams on 12/29/22. Associated Cases: 1:22-cv-01055-GBW, 1:22-cv-01096-GBW, 1:22-cv-01099-GBW, 1:22-cv-01100-GBW, 1:22-cv-01101-GBW (ntl) (Entered: 12/29/2022) (21) |
| Dec 15, 2022 | 26 | PROPOSED ORDER Scheduling (Amended) by AstraZeneca Pharmaceuticals LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP. (Joyce, Alexandra) (Entered: 12/15/2022) (21) |
| Dec 14, 2022 | 25 | NOTICE OF SERVICE of Plaintiffs' First Set of Requests (Nos. 1-10) to Alkem for the Production of Documents and Things filed by AstraZeneca Pharmaceuticals LP, ZS Pharma, Inc..(Joyce, Alexandra) (Entered: 12/14/2022) (2) |
| Dec 12, 2022 | 24 | MOTION for Pro Hac Vice Appearance of Attorney Lisa B. Pensabene - filed by AstraZeneca Pharmaceuticals LP, ZS Pharma, Inc.. (Silver, Daniel) (Entered: 12/12/2022) (4) |
| Dec 6, 2022 | 23 | ORAL ORDER: Having reviewed the parties' proposed scheduling order for the coordinated cases 22-cv-1055, 22-cv-1096, 22-cv-1099, 22-cv-1100, and 22-1101, a Rule 16 telephonic conference will be held on Monday, December 12, 2022 at 11:00 a.m. The parties shall arrange for the teleconference and shall provide chambers with the call-in information. ORDERED by Judge Gregory B. Williams on 12/6/22. Associated Cases: 1:22-cv-01055-GBW, 1:22-cv-01096-GBW, 1:22-cv-01099-GBW, 1:22-cv-01100-GBW, 1:22-cv-01101-GBW (ntl) (Entered: 12/06/2022) (0) |
| Dec 2, 2022 | 22 | Letter to The Honorable Gregory B. Williams from Alexandra M. Joyce, Esq. regarding Scheduling Order. (Attachments: # 1 Proposed Rule 16 Scheduling Order)(Joyce, Alexandra) (Entered: 12/02/2022) (Proposed Rule 16 Scheduling Order) (20) |
| Dec 2, 2022 | 22 | Letter to The Honorable Gregory B. Williams from Alexandra M. Joyce, Esq. regarding Scheduling Order. (Attachments: # 1 Proposed Rule 16 Scheduling Order)(Joyce, Alexandra) (Entered: 12/02/2022) (Main Document) (1) |
| Nov 23, 2022 | 21 | STIPULATION TO EXTEND TIME to meet and confer and submit a joint proposed scheduling order to December 2, 2022 - filed by AstraZeneca Pharmaceuticals LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP. (Joyce, Alexandra) (Entered: 11/23/2022) (4) |
| Nov 3, 2022 | 20 | ANSWER to 17 Answer to Complaint, Counterclaim by AstraZeneca Pharmaceuticals LP, ZS Pharma, Inc..(Silver, Daniel) (Entered: 11/03/2022) (25) |
| Oct 17, 2022 | 19 | STIPULATION and [Proposed] Order Regarding Case Coordination and Extension of Deadline for Case Schedule by AstraZeneca Pharmaceuticals LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP. (Joyce, Alexandra) (Entered: 10/17/2022) (5) |
| Oct 13, 2022 | 18 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Alkem Laboratories Ltd.. (Capuzzi, Kevin) (Entered: 10/13/2022) (3) |
| Oct 13, 2022 | 17 | ANSWER to 1 Complaint , COUNTERCLAIM against AstraZeneca Pharmaceuticals LP, ZS Pharma, Inc. by Alkem Laboratories Ltd..(Capuzzi, Kevin) (Entered: 10/13/2022) (30) |
| Oct 13, 2022 | 16 | MOTION for Pro Hac Vice Appearance of Attorney Zaiba Baig - filed by Alkem Laboratories Ltd.. (Capuzzi, Kevin) (Entered: 10/13/2022) (2) |
| Oct 13, 2022 | 15 | MOTION for Pro Hac Vice Appearance of Attorney Michael S. Weinstein - filed by Alkem Laboratories Ltd.. (Capuzzi, Kevin) (Entered: 10/13/2022) (2) |
| Oct 13, 2022 | 14 | MOTION for Pro Hac Vice Appearance of Attorney Manish K. Mehta - filed by Alkem Laboratories Ltd.. (Capuzzi, Kevin) (Entered: 10/13/2022) (2) |
| Sep 8, 2022 | 13 | Joint STIPULATION for Extension of Time to Respond to the Complaint by Alkem Laboratories Ltd.. (Capuzzi, Kevin) (Entered: 09/08/2022) (1) |
| Sep 8, 2022 | 12 | NOTICE of Appearance by Kevin M. Capuzzi on behalf of Alkem Laboratories Ltd. (Capuzzi, Kevin) (Entered: 09/08/2022) (1) |
| Aug 30, 2022 | 11 | MOTION for Pro Hac Vice Appearance of Attorney Hassen Sayeed, Daniel O'Boyle, and James Li - filed by AstraZeneca Pharmaceuticals LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP. (Attachments: # 1 Certifications for Hassen Sayeed, Daniel O'Boyle, and James Li)(Silver, Daniel) (Entered: 08/30/2022) (Certifications for Hassen Sayeed, Daniel O'Boyle, and James Li) (3) |
| Aug 30, 2022 | 11 | MOTION for Pro Hac Vice Appearance of Attorney Hassen Sayeed, Daniel O'Boyle, and James Li - filed by AstraZeneca Pharmaceuticals LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP. (Attachments: # 1 Certifications for Hassen Sayeed, Daniel O'Boyle, and James Li)(Silver, Daniel) (Entered: 08/30/2022) (Main Document) (3) |
| Aug 30, 2022 | 10 | NOTICE of Appearance of Lisa B. Pensabene by AstraZeneca Pharmaceuticals LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP (Silver, Daniel) (Entered: 08/30/2022) (3) |
| Aug 26, 2022 | 9 | DECLARATION of Service for Alkem Laboratories Ltd. by AstraZeneca Pharmaceuticals LP, ZS Pharma, Inc.. (Attachments: # 1 Exhibit A-B)(Joyce, Alexandra) (Entered: 08/26/2022) (Exhibit A-B) (8) |
| Aug 26, 2022 | 9 | DECLARATION of Service for Alkem Laboratories Ltd. by AstraZeneca Pharmaceuticals LP, ZS Pharma, Inc.. (Attachments: # 1 Exhibit A-B)(Joyce, Alexandra) (Entered: 08/26/2022) (Main Document) (2) |
| Aug 24, 2022 | 8 | VAC Notice, Consent, Non-Consent, Magistrate Referral (etg) (Entered: 08/24/2022) (1) |
| Aug 24, 2022 | 7 | ORAL ORDER: This case has been assigned to the District of Delaware's Vacant Judgeship ("VAC"). Detailed information relating to VAC cases may be found in the Court's Announcement of March 3, 2022 and Standing Order No. 2022-VAC-1 (March 9, 2022), which are found on the Court's website. Consistent with the foregoing Announcement and Standing Order, IT IS HEREBY ORDERED that the parties shall file the "Notice of Consent or Absence of Consent to Proceed Before a United States Magistrate Judge," being docketed along with the instant order, no later than sixty (60) days after service of the Complaint on the first defendant that is served. IT IS FURTHER ORDERED that the Notice, Consent, and Referral forms re: U.S. Magistrate Judge jurisdiction, previously docketed in this case, are VACATED. Issued by the Clerk of Court on 8/24/2022. (etg) (Entered: 08/24/2022) (0) |
| Aug 22, 2022 | 6 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (vfm) (Entered: 08/22/2022) (3) |
| Aug 22, 2022 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC, for Astrazeneca Pharamaceuticals LP,, ZS Pharma, Inc. filed by Astrazeneca Pharamaceuticals LP, ZS Pharma, Inc. (vfm) (Entered: 08/22/2022) (1) |
| Aug 22, 2022 | 4 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 7/14/2022. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 11/18/2025. (vfm) (Entered: 08/22/2022) (2) |
| Aug 22, 2022 | 3 | Summonses Issued (please complete the top portion of the form and print out for use/service)(apk). (Entered: 08/22/2022) (2) |
| Aug 22, 2022 | 2 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,877,255 ;9,592,253 ;9,913,860 ;10,300,087 ;10,695,365. (vfm) (Entered: 08/22/2022) (1) |
| Aug 22, 2022 | 1 | Complaint* (1) |
